SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-085273
Filing Date
2021-06-24
Accepted
2021-06-24 18:23:02
Documents
2
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120455d3_3.html 3  
1 OWNERSHIP DOCUMENT tm2120455d3_3.xml 3 7367
2 EXHIBIT 24 tm2120455d3_ex24.htm EX-24 8041
  Complete submission text file 0001104659-21-085273.txt   16828
Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Issuer) CIK: 0001736243 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4 GREENBRIAR LANE MONTVALE NJ 07645
Business Address
Sailer Carl (Reporting) CIK: 0001854182 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40536 | Film No.: 211044071